Microfluidics Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Microfluidics Market Report is Segmented by Product Type (Microfluidic-Based Devices, Microfluidic Components (Microfluidic Chips, Micro Pumps, Microneedles, and Other Components), Application (Drug Delivery, Point-Of-Care Diagnostics, Pharmaceutical, and Biotechnology Research (High-Throughput Screening, Proteomics, Genomics, Cell-Based Assay, Capillary Electrophoresis, and Other Pharmaceutical and Biotechnology Research), Clinical Diagnostics, and Other Applications), Material (Polymer, Silicone, Glass, and Other Materials), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The Market Size and Forecasts are Provided in Terms of Value (USD) for all the Above Segments.

Microfluidics Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Microfluidics Market Size

Microfluidics Market Summary
Study Period 2019 - 2030
Market Size (2025) USD 24.15 Billion
Market Size (2030) USD 41.23 Billion
CAGR (2025 - 2030) 11.29 %
Fastest Growing Market Asia Pacific
Largest Market North America
Market Concentration Low

Major Players

Microfluidics Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of Microfluidics Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

Microfluidics Market Analysis

The Microfluidics Market size is estimated at USD 24.15 billion in 2025, and is expected to reach USD 41.23 billion by 2030, at a CAGR of 11.29% during the forecast period (2025-2030).

Factors driving the market's expansion include a surging demand for Point of Care Diagnostics, escalating incidences of diverse diseases, quicker analysis turnaround times, and enhanced device portability.

The growing prevalence of infectious and chronic diseases, including cancer, diabetes, and cardiovascular conditions, is fueling the demand for Point of Care Diagnostics. This trend is anticipated to bolster the Microfluidics Market during the forecast period. For instance, data from the Institute for Health Metrics and Evaluation (IHME) in June 2023 highlighted that over half a billion individuals globally are living with diabetes. This condition spans across men, women, and children in every nation. Furthermore, projections indicate this figure could exceed 1.3 billion in the next three decades. Such an anticipated surge in diabetes cases underscores the urgency for innovative solutions, like novel porous microcapsules with β cells for diabetes treatment, leveraging Microfluidic Technology.

With the rise in cancer diagnoses, there's a parallel uptick in the demand for sophisticated cancer therapies, suggesting a bullish outlook for the market. For instance, data from the National Cancer Center of Japan revealed that in 2023, Japan witnessed approximately 1 million new cancer diagnoses. Given that Microfluidic Devices, including Microfluidic Chips, can simulate cancer metastasis and are adept at culturing multiple organoids from various cell types, the escalating cancer cases present a lucrative opportunity for market growth.

The fusion of Microfluidics and nanotechnology has transformed portable diagnostic devices, marking significant strides in disease detection. For instance, an article from the Royal Society of Chemistry in January 2024 emphasized that Microfluidic Devices, known for their simplicity, reliability, and sensitivity, can deliver rapid results with minimal sample volumes. These attributes make them essential for diagnosing diseases across plants, animals, and humans, suggesting a bullish outlook for the market.

Given these dynamics, the rising prevalence of chronic ailments like cancer, diabetes, and cardiovascular diseases, coupled with advancements in Microfluidic Technology, are poised to drive the Microfluidics Market's growth.

However, the integration of Microfluidic Technology with existing workflows and the low adoption in developing countries due to high prices are expected to hinder the market's growth during the forecast period.

Microfluidics Industry Overview

The Microfluidics Market is highly competitive and fragmented in nature, and in terms of market share, few major players dominate the market. However, with technological advancements and product innovations, mid-size to smaller Microfluidics Companies are increasing their market presence by introducing new technologies at affordable prices. Companies like uFluidix, Bio-Rad Laboratories Inc., Fluidigm Corporation, Illumina Inc., and PerkinElmer Inc. hold a substantial market share among Microfluidic Device Companies. The key players have been involved in various strategic alliances such as acquisitions, collaborations, and launches of advanced products to secure their positions in the global Microfluidics Market.

Microfluidics Market Leaders

  1. uFluidix

  2. Bio-Rad Laboratories Inc.

  3. Fluidigm Corporation

  4. Illumina Inc.

  5. PerkinElmer, Inc.

  6. *Disclaimer: Major Players sorted in no particular order
Microfluidics Market Concentration
Need More Details on Market Players and Competiters?
Download PDF

Microfluidics Market News

  • May 2024: Takara Bio USA Inc. introduced the dissolvable microfluidic transduction enhancer Lenti-X Transduction Sponge, which is incorporated with in vitro lentivirus-mediated gene delivery techniques. This sponge streamlines the workflow and provides high transduction efficiency in any cell type, facilitating downstream research applications in the gene and cell therapy domain.
  • May 2024: Fluidic Sciences Ltd. officially launched as a company and reintroduced the Fluidity One-M instrument, which was acquired to measure protein-protein interactions in solution. This instrument utilizes the advanced Microfluidic Diffusional Sizing (MDS) technology. With Fluidic Sciences entering the market, scientists gain a fresh avenue for superior protein biophysical characterization. This advancement propels biopharmaceutical R&D, focusing on areas like membrane protein characterization, vaccine responses, monoclonal therapeutic antibodies, and targeted protein degradation.

Microfluidics Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Demand for Point-of-care Testing
    • 4.2.2 Increasing Incidences of Various Diseases
    • 4.2.3 Faster Turn-around Time for Analysis and Improved Portability of Devices
  • 4.3 Market Restraints
    • 4.3.1 Integration of Microfluidics Technology with Existing Workflows
    • 4.3.2 Low Adoption in Developing Countries Due to High Prices
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION (Market Size by Value - USD)

  • 5.1 By Product Type
    • 5.1.1 Microfluidic-based Devices
    • 5.1.2 Microfluidic Components
    • 5.1.2.1 Microfluidic Chips
    • 5.1.2.2 Micro Pumps
    • 5.1.2.3 Microneedles
    • 5.1.2.4 Other Components
  • 5.2 By Application
    • 5.2.1 Drug Delivery
    • 5.2.2 Point-of-care Diagnostics
    • 5.2.3 Pharmaceutical and Biotechnology Research
    • 5.2.3.1 High-throughput Screening
    • 5.2.3.2 Proteomics
    • 5.2.3.3 Genomics
    • 5.2.3.4 Cell-based Assay
    • 5.2.3.5 Capillary Electrophoresis
    • 5.2.3.6 Other Pharmaceutical and Biotechnology Research
    • 5.2.4 Clinical Diagnostics
    • 5.2.5 Other Applications
  • 5.3 By Material
    • 5.3.1 Polymer
    • 5.3.2 Silicone
    • 5.3.3 Glass
    • 5.3.4 Other Materials
  • 5.4 By Geography
    • 5.4.1 North America
    • 5.4.1.1 United States
    • 5.4.1.2 Canada
    • 5.4.1.3 Mexico
    • 5.4.2 Europe
    • 5.4.2.1 France
    • 5.4.2.2 United Kingdom
    • 5.4.2.3 Germany
    • 5.4.2.4 Italy
    • 5.4.2.5 Spain
    • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
    • 5.4.3.1 China
    • 5.4.3.2 Japan
    • 5.4.3.3 India
    • 5.4.3.4 Australia
    • 5.4.3.5 South Korea
    • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle East and Africa
    • 5.4.4.1 GCC
    • 5.4.4.2 South Africa
    • 5.4.4.3 Rest of Middle East and Africa
    • 5.4.5 South America
    • 5.4.5.1 Brazil
    • 5.4.5.2 Argentina
    • 5.4.5.3 Rest of South America

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Ufluidix
    • 6.1.2 Bio-Rad Laboratories Inc.
    • 6.1.3 Emulate Inc.
    • 6.1.4 Unchained Labs LLC (Dolomite Microfluidics)
    • 6.1.5 Sphere Fluidics Limited
    • 6.1.6 Standard Biotools
    • 6.1.7 Illumina Inc.
    • 6.1.8 Micronit BV
    • 6.1.9 Perkinelmer Inc.
    • 6.1.10 Hesperos Inc.
    • 6.1.11 ZEON CORPORATION
    • 6.1.12 Bartels Mikrotechnik GmbH
    • 6.1.13 Agilent Technologies Inc.
    • 6.1.14 Quidelortho Corporation
    • 6.1.15 Fluigent
    • 6.1.16 Boston Pharmaceutical (NANOMIX CORPORATION)
    • 6.1.17 Biosurfit SA
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape Covers - Business Overview, Financials, Products and Strategies, and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Microfluidics Industry Segmentation

As per the scope of the report, microfluidics is a medical approach involving the precise control of small fluid samples for medical analysis. The sample sizes in microfluidics range from microliters to picoliters. At such low volumes, fluid transportation is governed significantly by its mass. The microfluidics market is segmented into product type, application, material, and geography. By product type, the market is segmented into microfluidic-based devices and microfluidic components. By microfluidic components, the market is segmented into microfluidic chips, micro pumps, microneedles, and other product types. By application, the market is segmented into drug delivery, point-of-care diagnostics, pharmaceutical and biotechnology research, clinical diagnostics, and other applications. By pharmaceutical and biotechnology research, the market is segmented into high-throughput screening, proteomics, genomics, cell-based assay, capillary electrophoresis, and other pharmaceutical and biotechnology research. By material, the market is segmented into polymer, silicone, glass, and other materials. By geography, the market is segmented into North America, Europe, Asia-Pacific, the Middle East and Africa, and South America. The report also covers the estimated market sizes and trends for 17 countries across major regions globally. The report offers the value (in USD) for the above segments.

By Product Type Microfluidic-based Devices
Microfluidic Components Microfluidic Chips
Micro Pumps
Microneedles
Other Components
By Application Drug Delivery
Point-of-care Diagnostics
Pharmaceutical and Biotechnology Research High-throughput Screening
Proteomics
Genomics
Cell-based Assay
Capillary Electrophoresis
Other Pharmaceutical and Biotechnology Research
Clinical Diagnostics
Other Applications
By Material Polymer
Silicone
Glass
Other Materials
By Geography North America United States
Canada
Mexico
Europe France
United Kingdom
Germany
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa GCC
South Africa
Rest of Middle East and Africa
South America Brazil
Argentina
Rest of South America
Need A Different Region or Segment?
Customize Now

Microfluidics Market Research FAQs

How big is the Microfluidics Market?

The Microfluidics Market size is expected to reach USD 24.15 billion in 2025 and grow at a CAGR of 11.29% to reach USD 41.23 billion by 2030.

What is the current Microfluidics Market size?

In 2025, the Microfluidics Market size is expected to reach USD 24.15 billion.

Who are the key players in Microfluidics Market?

uFluidix, Bio-Rad Laboratories Inc., Fluidigm Corporation, Illumina Inc. and PerkinElmer, Inc. are the major companies operating in the Microfluidics Market.

Which is the fastest growing region in Microfluidics Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).

Which region has the biggest share in Microfluidics Market?

In 2025, the North America accounts for the largest market share in Microfluidics Market.

What years does this Microfluidics Market cover, and what was the market size in 2024?

In 2024, the Microfluidics Market size was estimated at USD 21.42 billion. The report covers the Microfluidics Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Microfluidics Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Microfluidics Device Industry Report

The global microfluidics market is experiencing remarkable growth, driven by the demand for advanced diagnostics and an uptick in chronic diseases. Innovations in lab-on-a-chip and point-of-care diagnostics are rapidly advancing healthcare by enhancing diagnostic speed, accuracy, and cost-effectiveness. The integration with PCR for swift detection and innovations in drug delivery systems underscore microfluidics' role in evolving healthcare towards more effective and controlled solutions.

North America, with significant R&D and a strong healthcare infrastructure, leads market expansion into diverse applications, making diagnostics more accessible and revolutionizing healthcare efficiency. This evolution reflects microfluidics' pivotal role in shaping future medical science and global health betterment, as detailed in industry analyses by Mordor Intelligence™.

The market size and forecasts are provided in terms of value for all the above segments. The global market is segmented by product type, application, material, and geography. The market growth is driven by demand in various sectors such as drug delivery, point-of-care diagnostics, and pharmaceutical and biotechnology research.

The industry analysis shows that microfluidics is pivotal in enhancing diagnostic speed, accuracy, and cost-effectiveness. The market forecast predicts continued growth, driven by advancements in lab-on-a-chip technologies and point-of-care diagnostics. Industry reports highlight North America's role in leading market expansion and making diagnostics more accessible.

The market overview indicates that innovations in drug delivery systems are also playing a significant role in the market's evolution. The industry outlook is positive, with the market segmentation showing diverse applications across different regions. The market leaders are focusing on R&D to further revolutionize healthcare efficiency.

The industry information provided by Mordor Intelligence™ emphasizes the importance of microfluidics in shaping future medical science. The market data supports the industry trends of increasing demand for advanced diagnostics. The market review and market predictions highlight the continuous growth and innovation in the microfluidics market.